SkinBioTherapeutics plc (SBTX) Ord GBP0.01
Share news, reports & tips
30 September 2021 15:38
(Sharecast News) - Skin health-focussed life science company SkinBioTherapeutics updated the market on its commercialisation plans for 'AxisBiotix-Ps' on Thursday, which it described as its...
8 April 2021 13:01
(Sharecast News) - Skin health science company SkinBioTherapeutics has initiated a research programme with the University of Manchester, it announced on Thursday, to investigate and develop microbiome...
7 July 2020 13:42
(Sharecast News) - SkinBioTherapeutics updated the market on its operations on Tuesday, reporting that it ended the 12 months to 30 June with a "solid" cash balance of £2.1m, down from £2.5m at...
19 February 2020 14:48
(Sharecast News) - Skin health-focussed life science company SkinBioTherapeutics announced on Wednesday that its wholly-owned subsidiary, AxisBiotix, has signed a development agreement with Winclove...
20 November 2019 11:15
(Sharecast News) - Skin health-focussed life sciences company SkinBioTherapeutics has signed a commercial agreement with speciality chemicals giant Croda International, it announced on Wednesday.
4 July 2019 11:48
(Sharecast News) - Skin health-focussed life sciences company SkinBioTherapeutics updated the market on its operations and announced some changes to its board and executive team on Thursday.
8 April 2019 09:08
(Sharecast News) - Skin health-focussed life sciences company SkinBioTherapeutics released the results of its first human study on Monday, which was primarily undertaken to show the effects of its...
14 February 2019 10:40
(Sharecast News) - SkinBioTherapeutics on Thursday announced that it is seeking a "commercially experienced" replacement for Cath O'Neill, as she transitions away from the chief executive role...
25 October 2018 08:28
(Sharecast News) - The past year has seen SkinBioTherapeutics make "significant progress" with the development of its moisturising cream and efforts to begin human trials, the company said on...
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.